3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Surgical Procedures, Operative: new trials by email Literature Review of Surgical Procedures, Operative trials Research Report on Surgical Procedures, Operative
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Outcomes and Safety Trial Investigating Ecallantide's Effect on Reducing Surgical Blood Loss Volume in Subjects at High Risk of Bleeding Exposed to Cardio-pulmonary Bypass During Cardiac Surgery Ecallantide, Cyklokapron(R) - Bloodloss, Surgical Procedures, Operative | Phase 2 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 243 | 2009-06-01 | 2015-08-10 |
| A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume ecallantide, placebo - Bloodloss, Surgical Procedures, Operative | Phase 2 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 276 | 2009-03-01 | 2015-08-11 |
| Psychological Influences on Postoperative Recovery Preoperative Preparation Program (Child Life Specialist), Midazolam, Parental Presence during Induction of Anesthesia - Care, Postoperative, Pain, Postoperative | Phase 2 | Completed | University of California, Irvine | 241 | 2003-04-01 | 2023-09-07 |
Neurologic Manifestations (1) · Pain (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Postoperative Complications (1) · Signs and Symptoms (1)
ecallantide (2) · Allied Health Personnel (1) · Midazolam (1)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (2) · University of California, Irvine (1)
United States (3) · Canada (1) · Germany (1) · Poland (1)
Alistair Wheeler, MD, MFPM (2) · Zeev N Kain, MD, MBA (1)
R01HD037007 (1)